Literature DB >> 19176203

Bladder cancer.

James E Montie1, Peter E Clark, Mario A Eisenberger, Rizk El-Galley, Richard E Greenberg, Harry W Herr, Gary R Hudes, Deborah A Kuban, Timothy M Kuzel, Paul H Lange, Subodh M Lele, Jeffrey Michalski, Anthony Patterson, Kamal S Pohar, Jerome P Richie, Wade J Sexton, William U Shipley, Eric J Small, Donald L Trump, Phillip J Walther, Timothy G Wilson.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19176203     DOI: 10.6004/jnccn.2009.0002

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  17 in total

1.  Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding.

Authors:  Gary H Lyman; Nicole M Kuderer; Stephen J Freedland
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

2.  Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial.

Authors:  Bruce L Jacobs; Stephanie Daignault; Cheryl T Lee; Khaled S Hafez; Jeffrey S Montgomery; James E Montie; Jean E Humrich; Brent K Hollenbeck; David P Wood; Alon Z Weizer
Journal:  J Urol       Date:  2014-07-24       Impact factor: 7.450

3.  Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.

Authors:  Venu Chalasani; Wassim Kassouf; Joseph L Chin; Yves Fradet; Armen G Aprikian; Adrian S Fairey; Eric Estey; Louis Lacombe; Ricardo Rendon; David Bell; Ilias Cagiannos; Darrell Drachenberg; Jean-Baptiste Lattouf; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

4.  Characterization of aziridinylbenzoquinone DNA cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry.

Authors:  Sarah E Pierce; Lynn J Guziec; Frank S Guziec; Jennifer S Brodbelt
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

Review 5.  Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.

Authors:  Samuel A Funt; Jonathan E Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2016-11-22       Impact factor: 66.675

6.  Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.

Authors:  Jacob T Ark; Kirk A Keegan; Daniel A Barocas; Todd M Morgan; Matthew J Resnick; Chaochen You; Michael S Cookson; David F Penson; Rodney Davis; Peter E Clark; Joseph A Smith; Sam S Chang
Journal:  BJU Int       Date:  2014-04-03       Impact factor: 5.588

7.  Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.

Authors:  Taekmin Kwon; In Gab Jeong; JungBok Lee; Chunwoo Lee; Dalsan You; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-14       Impact factor: 4.553

8.  Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.

Authors:  Carolyn D Hurst; Fiona M Platt; Claire F Taylor; Margaret A Knowles
Journal:  Clin Cancer Res       Date:  2012-08-29       Impact factor: 12.531

9.  Use of radical cystectomy for patients with invasive bladder cancer.

Authors:  John L Gore; Mark S Litwin; Julie Lai; Elizabeth M Yano; Rodger Madison; Claude Setodji; John L Adams; Christopher S Saigal
Journal:  J Natl Cancer Inst       Date:  2010-04-16       Impact factor: 13.506

10.  The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis.

Authors:  Madhur Nayan; Bimal Bhindi; Julie L Yu; Muhammad Mamdani; Neil E Fleshner; Thomas Hermanns; Peter Chung; Michael Milosevic; Robert Bristow; Padraig Warde; Robert J Hamilton; Antonio Finelli; Michael A S Jewett; Alexandre R Zlotta; Srikala S Sridhar; Girish S Kulkarni
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.